Table 1 Demographic data of the study cohort
Gd− (n = 20) | Gd+ (n = 26) | p value | |
|---|---|---|---|
Age (mean ± SD) | 31.15 ± 10.37 | 36.15 ± 8.65 | 0.081 |
Sex (male/female) | 0.818 | ||
Male | 6 (30.00%) | 7 (26.92%) | |
Female | 14 (70.00%) | 19 (73.08%) | |
EDSS at sampling (median, Q1–Q2) | 2 (1–2.5) | 2 (1.5–2.13) | 0.819 |
OCGB (N/P) | 0.432 | ||
Negative | 1 (5.26%) | 0 (0.00%) | |
Positive | 18 (94.74%) | 25 (100.00%) | |
LS_OCMB (N/P) | 0.393 | ||
Negative | 14 (73.68%) | 16 (61.54%) | |
Positive | 5 (26.32%) | 10 (38.46%) | |
T2 lesions | 0.004 | ||
< 9 lesions | 12 (66.67%) | 4 (16.67%) | |
10–20 lesions | 5 (27.78%) | 10 (41.67%) | |
21–50 lesions | 1 (5.56%) | 8 (33.33%) | |
51–100 lesions | 0 (0.00%) | 2 (8.33%) |